Navigation Links
Study examines medicare use for Mohs micrographic surgery and surgical excision for skin cancer
Date:4/16/2012

CHICAGO An analysis of Medicare beneficiaries suggests that surgical treatment for nonmelanoma skin cancer (NMSC) increased substantially from 2001 through 2006, primarily due to a doubling in the rate of Mohs micrographic surgery procedures, according to a report published in the April issue of Archives of Dermatology, a JAMA Network publication.

More than 3 million NMSCs are diagnosed each year in the United States and the variety of treatment options include surgical excision and Mohs micrographic surgery (MMS), which examines 100 percent of the surgical margin during the procedure. Surgical excision is effective for most primary basal cell carcinomas but cure rates are higher with MMS in patients with recurrent, infiltrative and high-risk anatomical site cancers, such as on the face, the authors write in their study background. But the authors note there is debate about the efficacy of surgical treatment (MMS vs surgical excision) for primary NMSC and the cost-efficacy of MMS.

Kate V. Viola, M.D., M.H.S., of the Albert Einstein College of Medicine, New York, and colleagues conducted a retrospective analysis of Medicare beneficiaries undergoing surgery (MMS vs surgical excision) to treat NMSC. A total of 26,931 patients with NMSC were surgically treated from 2001 through 2006 in the researchers' 5 percent sample of Medicare beneficiaries. Of the operations, 9,802 (36.4 percent) were MMS and 17,129 (63.6 percent) were surgical excisions.

During the study period, the rate of surgical excision increased slightly (1.8 vs 2.1 per 100 Medicare beneficiaries), while the rate of MMS doubled (0.75 vs 1.5 per 100 Medicare beneficiaries). Compared with surgical excision, MMS was more likely to be performed on lesions on the lip (60.1 percent vs 39.9 percent) and eyelid (57.2 percent vs 42.8 percent). Atlanta had the highest proportion of patients with NMSC treated with MMS (45.1 percent). The authors note that a higher proportion of MMS was performed in younger patients.

"To our knowledge, this is the only study to examine the national patterns of use of MMS for NMSC over time. Patient age and lesion location were significantly associated with the type of surgery (MMS vs surgical excision), yet there were wide variations in regional MMS use and geographical disparity that warrant further investigation. Additional large, prospective studies are needed to further identify surgical treatment outcomes for NMSC," the authors conclude.


'/>"/>
Contact: Karen Peart
karen.peart@yale.edu
203-432-1326
JAMA and Archives Journals
Source:Eurekalert

Related medicine news :

1. UT MD Anderson study finds cancer related pain often undertreated
2. Tattoos, Piercings Tied to Heavier Drinking in French Study
3. Surgery Rates Rising for Non-Melanoma Skin Cancer: Study
4. Dissolvable Heart Artery Stents Appear Safe in Study
5. Study identifies potential treatment for lethal childhood leukemia
6. Study recommends ways to evaluate end-of-life care in nursing homes
7. Mayo Clinic breast cancer study finds new type of mutation
8. Decision guide reduced uncertainty over breast cancer prevention, study finds
9. Study Probes How Sad Movies Make Viewers Happy
10. Single Boomers Struggling as They Age: Study
11. Gay Adults Rejected by Parents Have Worse Health, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different movies ... as the host of the “Informed” series. The program focuses on many important issues ... focuses on thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, ...
(Date:4/27/2017)... ... April 27, 2017 , ... Today, Jefferson Health in ... Colorado, announced an agreement to create the Jane and Leonard Korman Respiratory Institute ... and Leonard Korman Family Foundation. The collaboration leverages the strengths of each organization ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, the leaders ... of Thinksport’s award-winning sunscreen they’ve used the same scientific approach to solving smelly, ... deodorants flood the aisles that contain harmful chemicals that should be put nowhere ...
(Date:4/27/2017)... ... April 27, 2017 , ... SyncDog, Inc. , the ... MobileIron Live! 2017 in Santa Clara, California. Each year, MobileIron Live! assembles ... helping organizations maximize the benefits of mobility in their operations securely. MobileIron ...
(Date:4/27/2017)... ... April 27, 2017 , ... Are you investing in ... in water-related accidents and drownings during the summer. While most of us assume this ... situations occur every day. Very few people are taking the time to learn how ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
Breaking Medicine Technology: